Molnupiravir and nirmatrelvir-ritonavir combination therapy should be considered for patients within 5 days of symptom onset.
Your search for evid returned 2871 results
Review and meta-analysis show improvements in functional exercise capacity vs standard of care.
Screening with blood pressure measurements has substantial net benefits and is recommended throughout pregnancy.
Combination of a patch and fast-acting nicotine replacement therapy also effective.
Safety concerns to consider for youth with diabetes who are restricting carbohydrates include growth deceleration, poor bone health.
Findings seen for 50 most common questions about false information, myths, and false and true contraindications.
Significant improvements seen in symptoms on days 28 and 56; no synergistic effect seen for combination treatment.
Health care professionals should be aware of these risks and select patients for treatment accordingly.